Biotechnology companies in the Washington region attracted less money from investors in 2014 than any other year since 1999, recent data show, even as the sector saw a significant increase in venture capital dollars in other parts of the country.
Local industry observers aren’t sounding alarms just yet. They say one down year, no matter how down it may be, doesn’t necessarily mean the region has fallen out of favor with life sciences investors.
{iframe}http://www.washingtonpost.com/news/capital-business/wp/2015/01/30/biotech-investments-hit-a-15-year-low-in-the-washington-region/{/iframe}